Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain; Cardiovascular Research Chair, UAB, Barcelona, Spain.
J Intern Med. 2014 Dec;276(6):618-32. doi: 10.1111/joim.12296. Epub 2014 Sep 25.
Atherosclerosis is a silent chronic vascular pathology that is the cause of the majority of cardiovascular ischaemic events. The evolution of vascular disease involves a combination of endothelial dysfunction, extensive lipid deposition in the intima, exacerbated innate and adaptive immune responses, proliferation of vascular smooth muscle cells and remodelling of the extracellular matrix, resulting in the formation of an atherosclerotic plaque. High-risk plaques have a large acellular lipid-rich necrotic core with an overlying thin fibrous cap infiltrated by inflammatory cells and diffuse calcification. The formation of new fragile and leaky vessels that invade the expanding intima contributes to enlarge the necrotic core increasing the vulnerability of the plaque. In addition, biomechanical, haemodynamic and physical factors contribute to plaque destabilization. Upon erosion or rupture, these high-risk lipid-rich vulnerable plaques expose vascular structures or necrotic core components to the circulation, which causes the activation of tissue factor and the subsequent formation of a fibrin monolayer (coagulation cascade) and, concomitantly, the recruitment of circulating platelets and inflammatory cells. The interaction between exposed atherosclerotic plaque components, platelet receptors and coagulation factors eventually leads to platelet activation, aggregation and the subsequent formation of a superimposed thrombus (i.e. atherothrombosis) which may compromise the arterial lumen leading to the presentation of acute ischaemic syndromes. In this review, we will describe the progression of the atherosclerotic lesion along with the main morphological characteristics that predispose to plaque rupture, and discuss the multifaceted mechanisms that drive platelet activation and subsequent thrombus formation. Finally, we will consider the current scientific challenges and future research directions.
动脉粥样硬化是一种沉默的慢性血管病理学,是大多数心血管缺血事件的原因。血管疾病的发展涉及内皮功能障碍、内膜内广泛的脂质沉积、先天和适应性免疫反应的加剧、血管平滑肌细胞的增殖和细胞外基质的重塑,导致动脉粥样硬化斑块的形成。高危斑块有一个大的无细胞富含脂质的坏死核心,上面有一个薄的纤维帽,浸润着炎症细胞和弥漫性钙化。形成新的脆弱和渗漏的血管,侵入扩张的内膜,有助于增大坏死核心,增加斑块的脆弱性。此外,生物力学、血液动力学和物理因素有助于斑块不稳定。当这些高危富含脂质的脆弱斑块侵蚀或破裂时,会将血管结构或坏死核心成分暴露于循环中,从而激活组织因子,随后形成纤维蛋白单层(凝血级联反应),同时募集循环血小板和炎症细胞。暴露的动脉粥样硬化斑块成分、血小板受体和凝血因子之间的相互作用最终导致血小板激活、聚集和随后形成叠加的血栓(即动脉粥样血栓形成),这可能会使动脉管腔受损,导致急性缺血综合征的发生。在这篇综述中,我们将描述动脉粥样硬化病变的进展,以及易导致斑块破裂的主要形态特征,并讨论驱动血小板激活和随后血栓形成的多方面机制。最后,我们将考虑当前的科学挑战和未来的研究方向。
J Intern Med. 2014-9-25
Heart Lung Circ. 2013-3-29
Eur Heart J. 2012-12-13
Drugs. 2010-11-1
Circulation. 1990-9
Bull Mem Acad R Med Belg. 2006
Handb Exp Pharmacol. 2012
J Intern Med. 2015-11
Int J Mol Med. 2025-10
Nat Rev Cardiol. 2025-6-22
Curr Atheroscler Rep. 2025-6-3
J Cardiovasc Dev Dis. 2025-5-15
Int J Angiol. 2025-1-13